Press Releases

Tjoapack continues to expand its global infrastructure with strategic investments in injectable packaging and cold chain capabilities

Inizio Evoke Announces Medical Leadership Evolution: Matthew Hoelzle Named Chief Medical Officer

Industry Leading RBQM Event Returns for 2025

CluePoints, the premier sponsor of RBQMLive and provider of leading statistical and AI-driven software solutions, has announced the full agenda and expert speaker line up for the 4th annual, award-winning event, RBQMLive.

Image Analysis Group (IAG) and Picture Health Announce Strategic Partnership to Advance AI-Driven Imaging Endpoints in Oncology Clinical Trials

IAG (imaging CRO) and Picture Health (AI biomarker platform) just announced a partnership to advance the use of AI-driven imaging biomarkers in oncology trials. This partnership brings together IAG’s expertise and its DYNAMIKA™ AI platform with Picture Health’s Px™ platform and multimodal AI biomarkers. Together, they aim to deliver: Faster insights Smarter patient stratification Earlier, more in-depth reads into oncology treatment outcomes Both companies are women-led, AI-driven, and deeply committed to reshaping clinical research through advanced imaging analytics.

New Mayo Clinic Studies Find MyPhenome Test Predicts Recurrent Weight Regain After Bariatric Surgery

Research presented at Digestive Disease Week 2025 is the first to show that the MyPhenome test can identify patients at risk for weight regain and those most likely to benefit from bariatric procedures.

Enhancing Clinical Trials for Faster, More Predictable Outcomes with WCG Study Accelerator

WCG Clinical has announced the launch of WCG Study Accelerator, an innovative solution built to streamline clinical trial processes and improve outcomes for sponsors and institutions worldwide.

START and OneOncology Partner To Expand Access to Early Phase Oncology Trials

This partnership will launch three new START research sites to bring early phase trials closer to patients in major U.S. communities.

Verista Highlights LABELQ Print and Inspection Verification System

Verista, a leading provider of automation, compliance, and quality solutions for the pharmaceutical industry, highlights the LABELQ Label & Print Reconciliation System, a groundbreaking platform engineered to transform label management for medical device, pharmaceutical, and contract manufacturers. LABELQ streamlines operations by integrating print, inspection, and accountability into a single, unified platform, significantly increasing efficiency and reducing operational complexity for small and medium batch production environments.

Astoriom Expands Global Footprint for Sample Stability Storage Services

Growth in dedicated sample stability facilities at Tramore (Ireland) site to meet demand for flexible, regulatory-compliant storage solutions

eClinical Solutions Welcomes Sean Lannan as Chief

Lannan and new Board of Directors member Jason Blessing will help propel the company’s next phase of growth

Abzena Announces Establishment of Scientific Advisory Board to Support Innovation Strategy

START Doses First U.S. Patient in Moderna’s Phase 1 Clinical Trial of mRNA-4106, a Pan-Tumor Antigen Therapy Candidate, in Solid Tumors

This major study milestone highlights START’s commitment to bringing novel cancer therapies to patients through community-based early-phase clinical trials.

CapeStart Helps Life Science Teams Scale Faster, Boost Productivity with New Release of MadeAi™, Award-Winning GenAI Platform

CapeStart announced a major new release of MadeAi™, its GenAI-based platform that expedites the synthesis of content and data for the life sciences. The platform and the MadeAi-LR solution for systematic literature review (SLR) help time-strapped teams to advance the pace of scientific research.

Inizio Evoke Supercharges Creative Leadership with Dual ECD Appointments

ELRIG Announces Keynote Speakers for Drug Discovery 2025

• Prof Heather Pinkett and Dr Dafydd Owen to lead ELRIG’s flagship event • Drug Discovery returns to Liverpool, 21–22 October 2025 to celebrate “A Festival of Life Science” • Event supported by VisitBritain showcases UK life science sector and extends international reach

Hovione and Firstgene announce strategic collaboration to advance virus-like particle platform for liver cancer  

GeneFab and RegCell Announce Strategic Partnership to Advance Autoimmune Cell Therapy into U.S. Clinical Trials

GenNext Technologies and Thermo Fisher Scientific Collaborate to Simplify Structural Biology for Faster Biotherapeutic Development

GenNext® Technologies, Inc. is collaborating with Thermo Fisher Scientific to provide a simplified structural biology workflow designed to improve biotherapeutic development

Elegen Expands ENFINIA™ Platform with IVT Ready DNA to Streamline RNA Therapeutics Development

Elegen expanded it's ENFINIA cell-free gene synthesis platform with the launch of an early access program for IVT Ready DNA targeted toward RNA therapeutics, cell and gene therapies, and personalized cancer vaccines. ENFINIA IVT Ready DNA offers full-length, high-complexity, high-accuracy linear DNA with a long poly(A) tail, manufactured cell-free and delivered in as few as 10 days, ready for immediate use to speed genetic medicine development.

Mayo Clinic Study Uses Phenomix AI Algorithm to Predict GLP-1 Side Effects, Advancing Personalized Obesity Care and Drug Development

Study presented at DDW 2025 finds genetic risk scores can identify patients at higher risk of nausea from GLP-1 therapies, supporting the development of more targeted treatment decisions and advancing pharmaceutical R&D.